Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.

ABSTRACT:

Background

Evidence on the economic impact of chronic obstructive pulmonary disease (COPD) for third-party payers and society based on large real world datasets are still scarce. Therefore, the aim of this study was to estimate the economic impact of COPD severity and its comorbidities, stratified by GOLD grade, on direct and indirect costs for an unselected population enrolled in the structured German Disease Management Program (DMP) for COPD.

Methods

All individuals enrolled in the DMP COPD were included in the analysis. Patients were only excluded if they were not insured or not enrolled in the DMP COPD the complete year before the last DMP documentation (at physician visit), had a missing forced expiratory volume in 1 s (FEV₁) measurement or other missing valu

SUBMITTER: Kirsch F 

PROVIDER: S-EPMC6785905 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature